Tags : Kaken

PharmaShots Weekly Snapshot (October 14-18, 2019)

1. Johnson & Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US Published: Oct 18, 2019 | Tags: JnJ, Initiates, Voluntarily, Recall, Baby Powder, US 2. AbbVie’s Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis Published: Oct 18, 2019 | Tags: AbbVie, Rinvoq, Upadacitinib, Receives, […]Read More

Sanofi and Kaken to Terminate their Co-Marketing Agreement for Clexane

Shots: In accordance with the expiration of the effective period of the co-marketing agreement, the companies will terminate their co-marketing agreement for Clexane SC Kit 2000 IU on Dec 31, 2019 In Jan’2008, Sanofi got manufacturing and marketing approval for Clexane SC Kit 2000 IU while Kaken initiated marketing and information service activities in Jul’2010 […]Read More